Zepzelca | Lurbinectedin Injection

✓ Selective transcription inhibitor technology

✓ Preferred 2nd-line treatment for small cell lung cancer

✓ Inhibits tumor-associated macrophages

✓ Manageable safety profile with 30-minute IV infusion

✓ Essential lung cancer therapeutic innovation

Guaranteed Safe Checkout

Onlinemedex Features:-

Fulfilled-using-ems

Generic Name :	Lurbinectedin
Drug class:	Alkylating Agent (RNA Poly. II Inhib.)
CSA Schedule:	Non-controlled drug
Approval:	FDA approved 2020

Reviews

There are no reviews yet.

Be the first to review “Zepzelca | Lurbinectedin Injection”